AMBICA PHARMA
Natdac 60

Natdac 60

Send Inquiry

A well renowned manufacturing company in the pharmaceutical industry, we are supplying the best stock of Natdac 60. Recommended for use in combination with sofosbuvir, this medicine is prescribed for the treatment of patients with chronic HCV genotype 3 infections. The Natdac 60 has completely revolutionized the management of hepatitis C as it is administered for the treatment without the requirement of interferon like ribavirin.

Key points:

 

  • Generic name Daclatasvir
  • Excellent inhibitors of non-structural protein 5A (NS5A)
  • Highly active against multiple Genotypes

Daclatasvir is an inhibitor of non-structural protein 5A (NS5A). Each film coated tablet contains: Daclatasvir Dihydrochloride equivalent to Daclatasvir 60 mg. Daclatasvir is white to yellow colour solid and freely soluble in water. Daclatasvir is prescribed for the treatment of patients with chronic HCV genotype 3 infections along with Sofosbuvir 400mg tablets. Daclatasvir has revolutionized the management of HEPATITIS C by offering Ribavirin and Peg-interferon free treatment for all the genotypes of Hepatitis C.